HMG-CoA reductase is not the site of the primary defect in phytosterolemia

Journal of Lipid Research

Volumn 39, Issue 5, 1998, Pages 1046-1054

  Berger, G M B ^a   Pegoraro, R J ^a   Patel, S B ^b   Naidu, P ^a   Rom, L ^a   Hidaka, H ^c   Marais, A D ^d   Jadhav, A ^e   Naoumova, R P ^e   Thompson, G R ^e  

^a UNIVERSITY OF NATAL   (South Africa)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Cholesterol synthesis; Cholestyramine; Family linkage studies; HRase gene; Lathosterol; Mevalonic acid; Plant sterols; Sitosterolemia

Indexed keywords

COLESTYRAMINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LATHOSTEROL; MEVALONIC ACID; PHYTOSTEROL; SITOSTEROL;

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CHOLESTEROL SYNTHESIS; CLINICAL ARTICLE; DNA POLYMORPHISM; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE CONTROL; GENE EXPRESSION; HUMAN; INTRON; PHENOTYPE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; XANTHOMATOSIS;

EID: 15644382441     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Bhattacharyya, A. K., and W. E. Connor. 1974. β-Sitosterolemia and xanthomatosis: a newly described lipid storage disease in two sisters. J. Clin. Invest. 53: 1033-1043.
2. Miettinen, T. 1980. Phytosterolaemia, xanthomatosis and premature atherosclerotic disease: a case with high plant sterol absorption, impaired sterol elimination and low cholesterol synthesis. Eur. J. Clin. Invest. 10: 27-35.
3. Bjorkhem, I., and K. M. Boberg. 1996. Inborn errors in bile acid biosynthesis and storage of sterols other than cholesterol. In Metabolic and Molecular Bases of Inherited Disorders, Vol. 2, 7th ed. R. Scriver, A. L. Baudet, W. S. Sly, and D. Valle, editors. McGraw-Hill Inc., Health Professions Division, New York. 2073-2099.
4. Watts, G. F., and W. D. Mitchell. 1992. Clinical and metabolic findings in a patient with phytosterolaemia. Ann. Clin. Biochem. 29: 231-236.
5. Berger, G. M. B., W. M. Deppe, A. D. Marais, and M. Biggs. 1994. Phytosterolaemia in three unrelated South African families. Postgrad. Med. J. 70: 631-637.
6. Salen, G., V. Shore, G. S. Tint, T. Forte, S. Shefer, I. Horak, E. Horak, B. Dayal, L. Nguyen, A. K. Batta, F. T. Lindgren, and P. O. Kwiterovich. 1989. Increased sitosterol absorption, decreased removal, and expanded body pools compensate for reduced cholesterol synthesis in sitosterolemia with xanthomatosis. J. Lipid Res. 30: 1319-1330.
7. Lutjohann, D., I. Bjorkhem, U. F. Beil, and K. von Bergmann. 1995. Sterol absorption and sterol balance in phytosterolemia evaluated by deuterium-labelled sterols: effect of sitostanol treatment. Lipid Res. 36: 1763-1773.
8. Gregg, R. E., W. E. Connor, D. S. Lin, and H. B. Brewer, Jr. 1986. Abnormal metabolism of shellfish sterols in a patient with sitosterolemia and xanthomatosis. J. Clin. Invest. 77: 1864-1872.
9. Nguyen, L. B., S. Shefer, G. Salen, I. Horak, G. S. Tint, and D. J. McNamara. 1988. The effect of abnormal plasma and cellular sterol content and composition on low-density lipoprotein uptake and degradation by monocytes and lymphocytes in sitosterolemia with xanthomatosis. Metabolism. 37: 346-351.
10. Salen, G., I. Horak, M. Rothkopf, J. L. Cohen, J. Speck, G. S. Tint, V. Shore, B. Dayal, T. Chen, and S. Shefer. 1985. Lethal atherosclerosis associated with abnormal plasma and tissue sterol composition in sitosterolaemia with xanthomatosis. J. Lipid Res. 26: 1126-1133.
11. Bhattacharyya, A. K., W. E. Connor, D. S. Lin, M. M. McMurry, and R. S. Shulman. 1991. Sluggish sitosterol turnover and hepatic failure to excrete sitosterol into bile cause expansion of body pool of sitosterol in patients with sitosterolemia and xanthomatosis. Arterioscler. Thromb. 11: 1287-1294.
12. Lin, H. J., C. Wang, G. Salen, K. C. Lam, and T. K. Chan. 1983. Sitosterol and cholesterol metabolism in a patient with coexisting phytosterolemia and cholestanolemia. Metabolism. 32: 126-133.
13. Boyd, G. S., M. J. G. Brown, N. G. Hattersley, and K. E. Suckling. 1974. Studies on the specificity of the rat liver microsomal cholesterol 7α-hydroxylase. Biochim. Biophys. Acta. 337: 132-135.
14. 21-bile acids from plant sterols in the rat. J. Biol. Chem. 265: 7967-7975.
15. 24-bile acid in humans. J. Lipid Res. 31: 1083-1088.
16. Salen, G., G. S. Tint, S. Shefer, V. Shore, and L. Nguyen. 1992. Increased sitosterol absorption is offset by rapid elimination to prevent accumulation in heterozygotes with sitosterolemia. Arterioscler. Thromb. 12: 563-568.
17. Nguyen, L. B., G. Salen, S. Shefer, G. S. Tint, V. Shore, and G. C. Ness. 1990. Decreased cholesterol biosynthesis in sitosterolemia with xanthomatosis: diminished mononuclear leucocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and enzyme protein associated with increased low-density lipoprotein receptor function. Metabolism. 39: 436-443.
18. Nguyen, L. B., S. Shefer, G. Salen, G. C. Ness, F. G. Zaki, and I. Rani. 1990. A molecular defect in hepatic cholesterol biosynthesis in sitosterolemia with xanthomatosis. J. Clin. Invest. 86: 923-931.
19. Hidaka, H., T. Nakamura, T. Aoki, H. Kojima, Y. Nakajima, K. Kosugi, F. Hatanaka, M. Harada, M. Kobayashi, A. Tamura, T. Fujii, and Y. Shigeta. 1990. Increased plasma plant sterol levels in heterozygotes with sitosterolemia and xanthomatosis. J. Lipid Res. 31: 881-888.
20. Zuliani, G., and H. H. Hobbs. 1990. A high frequency of length polymorphisms in repeated sequences adjacent to Alu sequences. Am. J. Hum. Genet. 46: 963-969.
21. Leitersdorf, E., M. Hwang, and K. L. Luskey. 1990. ScrFI polymorphism in the 2nd intron of the HMGCR gene. Nucleic Acids Res. 18: 5584.
22. Scoppola, A., V. M. Maher, G. R. Thompson, N. B. Rendell, and G. W. Taylor. 1991. Quantitation of plasma mevalonic acid using gas chromatography-electron capture mass spectrometry. J. Lipid Res. 32: 1057-1060.
23. Naoumova, R. P., A. D. Marais, J. Mountney, J. C. Firth, N. B. Rendell, G. W. Taylor, and G. R. Thompson. 1996. Plasma mevalonic acid, an index of cholesterol synthesis in vivo and responsiveness to HMG CoA reductase inhibitors in familial hypercholesterolaemia. Atherosclerosis. 119: 203-213.
24. Wolthers, B. G., H. T. Walrecht, J. C. van der Molen, G. T. Nagel, J. J. van Doormaal, and P. N. Wijnandts. 1991. Use of determinations of 7-lathosterol (5α-cholest-7-en-3β-ol) and other cholesterol precursors in serum in the study and treatment of disturbances of sterol metabolism, particularly cerebrotendinous xanthomatosis. J. Lipid Res. 32: 603-612.
25. Kempen, H. J. M., J. F. C. Glatz, J. A. Gevers Leuven, and M. B. van de Voort. 1988. Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans. J. Lipid Res. 29: 1149-1155.
26. Hixson, J. E., and D. T. Vernier. 1990. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 31: 545-548.
27. Brook, J. D., M. E. McCurrach, H. G. Harley, A. J. Buckler, D. Church, H. Aburantani, K. Hunter, V. P. Stanton, J-P. Thirion, T. Hudson, R. Sohn, B. Zemelman, R. G. Snell, S. A. Rundle, S. Crow, J. Davies, P. Shelbourne, J. Buxton, C. Jones, V. Juvonen, K. Johnson, P. S. Harper, D. J. Shaw, and D. E. Housman. 1992. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell. 68: 799-808.
28. Weiss, E. H., P. F. Bray, M. Tayback, S. P. Schulman, T. S. Kickler, L. C. Becker, J. L. Weiss, G. Gerstenblith, and P. J. Goldschmidt-Clermont. 1996. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N. Engl. J. Med. 334: 1090-1094.
29. Ito, T., T. Seyama, T. Hayashi, T. Mizuno, K. S. Iwamoto, N. Tsuyama, K. Dohi, N. Nakamura, and M. Akiyama. 1994. Hae III polymorphism in intron I of the human p53 gene. Hum. Genet. 93: 222.
30. McDaniel, T., D. Carbone, T. Takahashi, P. Chumakov, E. H. Chang, K. F. Pirollo, J. Yin, Y. Huang, and S. J. Meltzer. 1991. The MspI polymorphism in intron 6 of p53 (TP53) detected by digestion of PCR products. Nucleic Acids Res. 19: 4796.
31. Pfohl, M., R. P. Naoumova, C. Klass, W. Knisel, B. Jakober, T. Risler, and G. R. Thompson. 1994. Acute and chronic effects on cholesterol biosynthesis of LDL-apheresis with or without concomitant HMG-CoA reductase inhibitor therapy. J. Lipid Res. 35: 1946-1955.
32. Parker, T. S., D. J. McNamara, C. D. Brown, R. Kolb, E. H. Ahrens, Jr., A. W. Alberts, J. Tobert, J Chen, and P. J. De Schepper. 1984. Plasma mevalonate as a measure of cholesterol biosynthesis in man. J. Clin. Invest. 74: 795-804.
33. Pappu, A. S., and D. R. Illingworth. 1989. Contrasting effects of lovastatin and cholestyramine on low-density cholesterol and 24-h urinary mevalonate excretion in patients with heterozygous familial hypercholesterolaemia. J. Lab. Clin. Med. 114: 554-562.
34. Parker, T. S., D. J. McNamara, C. Brown, D. Garrigan, R. Kolb, H. Batwin, and E. H. Ahrens, Jr. 1982. Mevalonic acid in human plasma: relationship of concentration and arcadian rhythm to cholesterol synthesis rates in man. Proc. Natl. Acad. Sci. USA. 79: 3037-3041.
35. Jones, P. J. H., A. S. Pappu, D. R. Illingworth, and C. A. Leitch. 1992. Correspondence between plasma mevalonic acid levels and deuterium uptake in measuring human cholesterol synthesis. Eur. J. Clin. Invest. 22: 609-613.
36. Lindenthal, B., A. Simatupag, M. T. Dotti, A. Federico, D. Lutjohann, and K. von Bergmann. 1996. Urinary excretion of mevalonic acid as an indicator of cholesterol synthesis. J. Lipid Res. 37: 2193-2201.
37. Yoshida, T., A. Hounda, N. Tanaka, Y. Matsuzaki, B. He, T. Osuga, N. Kobajashi, K. Ozawa, and H. Miyazaki. 1993. Simultaneous determination of mevalonate and 7α-hydroxy-cholesterol in human plasma by gas chromatography-mass spectrometry as indices of cholesterol and bile acid biosynthesis. J. Chromatogr. 613: 185-193.
38. Illingworth, D. R., S. Bacon, A. S. Pappu, and G. J. Sexton. 1992. Comparative hypolipidemic effects of lovastatin and simvastatin in patients with heterozygous familial hypercholesterolemia. Atherosclerosis. 96: 53-64.
39. Gylling, H., and T. A. Miettinen, 1988. Serum noncholesterol sterols related to cholesterol metabolism in familial hypercholesterolemia. Clin. Chim. Acta. 178: 41-49.
40. Miettinen, T. A. 1969. Serum squalene and methyl sterols as indicators of cholesterol synthesis in vivo. Life Sci. 8: 713-721.
41. Bjorkhem, I., T. A. Miettinen, E. Reihner, S. Ewerth, and K. Einarsson. 1987. Correlation between serum levels of some cholesterol precursors and activity of HMG-CoA reductase in human liver. J. Lipid Res. 28: 1137-1143.
42. Elmberger, P. G., A. Kalen, E. Lund, M. Eriksson, L. Berglund, B. Angelin, and G. Dallner. 1991. Effects of pravastatin and cholestyramine on products of the mevalonate pathway in familial hypercholesterolemia. J. Lipid Res. 32: 935-940.
43. Strandberg, T. E., R. S. Tilvis, and T. A. Miettinen. 1990. Metabolic variables of cholesterol during squalene feeding in humans: comparison with cholestyramine treatment. J. Lipid Res. 31: 1637-1643.
44. Reihner, E., M. Rudling, D. Stahlberg, L. Berglund, S. Werth, I. Bjorkhem, S. Einarsson, and B. Angelin. 1990. Influence of pravastatin a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol. N. Engl. J. Med. 323: 224-228.
45. Naoumova, R. P., S. Dunn, L. Rallidis, O. Abu-Mohana, C. Neuwirth, N. B. Rendell, G. W. Taylor, and G. R. Thompson. 1997. Prolonged inhibition of cholesterol synthesis explains the efficacy of atorvastatin. J. Lipid Res. 38: 1496-1500.
46. Goldstein, J. L., and M. S. Brown. 1990. Regulation of the mevalonate pathway. Nature. 343: 425-430.
47. Cobb, M. M., G. Salen, G. S. Tint, J. Greenspan, and L. B. Nguyen. 1996. Sitosterolemia: girl and her heterozygous father. Metabolism. 45: 673-679.
48. Boberg, K. M., J. E. Akerlund, and I. Bjorkhem. 1989. Effect of sitosterol on the rate-limiting enzymes in cholesterol synthesis and degradation. Lipids. 24: 9-12.
49. Shefer, S., G. Salen, L. B. Bullock, L. B. Nguyen, G. C. Ness, Z. Vhao, P. F. Belamarich, I. Chowdhary, S. Lerner, A. K. Batta, and G. S. Tint. 1994. The effect of increased hepatic sitosterol on the regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and cholesterol 7 alpha-hydroxylase in the rat and sitosterolemic homozygotes. Hepatology. 20: 213-219.
50. Nguyen, L. B., G. Salen, S. Shefer, J. Bullock, T. Chen, G. S. Tint, I. R. Chowdhary, and S. Lerner. 1994. Deficient ilial 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in sitosterolemia: sitosterol is not a feedback inhibitor of intestinal cholesterol biosynthesis. Metabolism. 43: 855-859.
51. Field, F. J., E. Born, and S. N. Mathur. 1997. Effect of micellar beta-sitosterol on cholesterol metabolism in CaCo-2 cells. J. Lipid Res. 37: 348-360.
52. Straka, M. S., and S. R. Panini. 1995. Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by mevalonate. Arch. Biochem. Biophys. 317: 235-243.
53. Giron, M. D., C. M. Havel, and J. A. Watson. 1994. Mevalonate-mediated suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase function in alpha-toxin-perforated cells. Prof. Natl. Acad. Sci. USA. 91: 6398-6402.
54. Bradfute, D. L., and R. D. Simoni. 1994. Non-sterol compounds that regulate cholesterogenesis. Analogues of farnesyl pyrophosphate reduce 3-hydroxy-3-methylglutaryl-coenzyme A reductase levels. J. Biol. Chem. 269: 6645-6650.
55. Choi, J. W., and D. M. Peffley. 1995. 3′-Untranslated sequences mediate post-transcriptional regulation of 3-hydroxy-3-methylglutaryl-CoA reductase mRNA by 25-hydroxycholesterol. Biochem. J. 307: 233-238.
56. Feingold, K. R., A. S. Pollock, A. H. Moser, J. K. Shigenaga, and C. Grunfeld. 1995. Discordant regulation of proteins of cholesterol metabolism during the acute phase response. J. Lipid Res. 36: 1474-1482.
57. Cuthbert, J. A., and P. E. Lipsky. 1992. Differential regulation of the expression of 3-hydroxy-3-methylglutaryl coenzyme A reductase, synthase, and low density lipoprotein receptor genes. J. Lipid Res. 33: 1157-1163.
58. Vitols, S., S. Norgren, G. Julliusson, L. Tatidis, and H. Luthman. 1994. Multilevel regulation of low-density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in normal and leukaemic cells. Blood. 84: 2689-2698.
59. Sheng, Z., H. Otani, M. S. Brown, and J. L. Goldstein. 1995. Independent regulation of sterol regulatory element-binding proteins 1 and 2 in hamster liver. Proc. Natl. Acad Sci. USA. 92: 935-938.
60. Ness, G. C., S. Eales, D. Lopez, and Z. Zhao. 1994. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression by sterols and nonsterols in rat liver. Arch. Biochem. Biophys. 308: 420-425.
61. Sato, R., J. L. Goldstein, and M. S. Brown. 1993. Replacement of serine-871 of hamster 3-hydroxy-3-methylglutaryl-CoA reductase prevents phosphorylation by AMP-activated kinase and blocks inhibition of sterol synthesis induced by ATP depletion. Proc. Natl. Acad. Sci. USA. 90: 9261-9265.